Yes. Diabetes can raise ALT and AST, often through fatty liver, insulin resistance, or liver scarring that needs a closer medical workup.
A high liver enzyme result can feel like a curveball, especially when you were only expecting an A1c check or routine blood work. Diabetes does not always mean your liver is in trouble, but diabetes and liver disease often travel together, so a raised ALT or AST should not be brushed off.
In many people, the link is fat buildup in the liver. In others, the enzyme rise comes from alcohol, medicines, viral hepatitis, gallbladder trouble, or a problem that has nothing to do with diabetes at all. That is why the number itself is only the start. What matters is the pattern, how long it has been there, and what else is going on in the rest of the blood work.
Can Diabetes Cause Liver Enzymes To Be High? Why It Happens
Yes, it can. Still, diabetes is often part of the chain rather than the whole story by itself. Type 2 diabetes is tightly linked with insulin resistance, higher triglycerides, belly fat, and fatty liver. When fat builds up inside liver cells, those cells can leak enzymes into the bloodstream. That is one of the most common reasons ALT and AST climb.
Type 1 diabetes can also sit beside high liver enzymes, though the path is less often fatty liver alone. Celiac disease, autoimmune liver disease, medicine effects, and swings in glucose control can all enter the picture. The type of diabetes, your other lab results, and your health history all shape what the enzyme rise means.
What ALT And AST Are Telling You
ALT and AST are enzymes found inside cells. ALT is more closely tied to the liver. AST can rise from the liver too, but it can also rise with muscle injury, hard training, and a few other conditions. So a raised AST does not always point straight at liver disease.
These tests do not measure how well the liver is doing its job on their own. They are more like smoke signals. Mild elevations can show early irritation. A normal result does not rule out fatty liver or even scarring, which is why symptoms, platelet count, bilirubin, alkaline phosphatase, and imaging still matter.
Fatty Liver Is Often The Missing Link
The liver condition now called MASLD was once known as NAFLD. It is common in people with insulin resistance and type 2 diabetes. In plain terms, fat collects in the liver. Some people stay at that stage for years. Others move into a more inflamed form, called MASH, which can lead to scar tissue and cirrhosis over time.
According to NIDDK’s diagnosis page for NAFLD and NASH, doctors use blood tests, imaging, and sometimes liver biopsy to sort out fatty liver from other causes. The same page notes that blood work alone cannot settle the whole question. That matters because a person can have fatty liver with normal enzymes, while another person can have raised enzymes from a cause outside the liver.
Clues That Help Explain The Rise
When a clinician looks at high liver enzymes in someone with diabetes, they are piecing together a bigger story. A mild ALT rise in a person with central weight gain and high triglycerides points one way. A sharp jump after a new drug, fever, jaundice, or severe right upper belly pain points another way. Context changes everything.
That is why repeat testing is common. One odd result can happen after a virus, a hard workout, or a medication change. A result that stays high over weeks or months needs more attention.
| Possible Cause | How It Fits With Diabetes Or Liver Tests | Usual Next Move |
|---|---|---|
| MASLD fatty liver | Common in type 2 diabetes, insulin resistance, higher triglycerides, and extra weight around the waist | Repeat labs, review metabolic risk, and order liver imaging if needed |
| MASH or liver scarring | Enzymes may stay up for months, or platelets may drift down as scar tissue builds | Risk scoring such as FIB-4, then elastography or specialist referral |
| Medicine effect | Some drugs can irritate the liver; timing after a new medicine can be a clue | Review the full medication and supplement list |
| Alcohol use | Can raise AST and ALT and can stack on top of fatty liver | Ask about intake pattern and check the rest of the panel |
| Viral hepatitis | Can cause a new or chronic enzyme rise that has nothing to do with glucose control | Order hepatitis testing when the history or pattern fits |
| Gallbladder or bile duct trouble | Often lifts alkaline phosphatase and bilirubin more than ALT alone | Look for pain, jaundice, dark urine, and get imaging |
| Muscle injury or hard exercise | AST can rise even when the liver is not the source | Check symptoms, timing, and sometimes a CK level |
| Autoimmune or iron overload disorders | Less common, but they can sit in the background and be missed early | Order targeted blood tests if the basic workup is unrevealing |
What The Pattern Can Tell You
A small bump in ALT is common in fatty liver. A mixed pattern with alkaline phosphatase or bilirubin going up can hint at bile flow trouble. An AST that runs higher than ALT can show alcohol-related injury, late scarring, or a muscle source. There is overlap, so no single ratio or number should be read in isolation.
The 2025 ADA consensus report on MASLD in prediabetes and type 2 diabetes pushes clinicians to think about liver disease early in people with diabetes. That shift matters because fatty liver can sit quietly for years. By the time symptoms show up, scar tissue may already be present.
When You Should Get Checked Promptly
Call your clinician soon if high liver enzymes show up with any of these signs:
- Yellow skin or eyes
- Dark urine or pale stools
- New swelling in the belly or legs
- Vomiting, fever, or strong right upper belly pain
- Confusion, unusual sleepiness, or easy bleeding
Those signs do not prove a liver emergency, but they do raise the stakes. A mild lab blip with no symptoms is one thing. A lab change plus jaundice or pain is another.
How Doctors Usually Sort It Out
The workup often starts with a repeat liver panel and a close review of alcohol intake, medicines, over-the-counter pain relievers, herbs, and workout habits. Many clinicians also check hepatitis tests, platelets, bilirubin, alkaline phosphatase, albumin, and sometimes iron studies or autoimmune markers.
MedlinePlus liver function tests notes that these blood tests measure different substances tied to liver health and that no single result should be read on its own. In diabetes care, age plus routine lab values can also be used to work out a fibrosis score such as FIB-4. That helps flag people who may need imaging like ultrasound or liver stiffness testing.
| Next Step | What It Helps Show | Why It Matters |
|---|---|---|
| Repeat liver panel | Whether the rise was brief or is sticking around | A one-time bump is handled differently from a steady pattern |
| Medication and alcohol review | Hidden triggers outside diabetes itself | Fixing the cause can bring enzymes down |
| FIB-4 or other fibrosis score | Chance of scar tissue | Helps sort who needs imaging or referral |
| Ultrasound or elastography | Fat in the liver and liver stiffness | Can spot disease that blood work misses |
| Targeted blood tests | Hepatitis, iron overload, or autoimmune disease | Prevents fatty liver from becoming the default answer every time |
What Often Helps Bring The Numbers Down
If fatty liver is the driver, better glucose control, weight loss when needed, lower triglycerides, and regular activity can all help. Even a modest drop in body weight can improve liver fat. The same habits that help diabetes often help the liver too.
Still, do not self-treat a persistent enzyme rise as “just fatty liver.” People with diabetes can also have hepatitis, gallstones, autoimmune disease, medicine-related injury, or scar tissue that needs closer follow-up. A neat story is nice, but a correct one is better.
If you are staring at abnormal results right now, ask what pattern was high, how high it was, whether it needs a repeat test, and whether you should be checked for fatty liver or fibrosis. That gives you a plan instead of a guessing game.
References & Sources
- National Institute of Diabetes and Digestive and Kidney Diseases.“Diagnosis of NAFLD & NASH.”Explains how doctors use blood tests, imaging, and biopsy to sort out fatty liver and related liver injury.
- American Diabetes Association.“Metabolic Dysfunction–Associated Steatotic Liver Disease (MASLD) in Prediabetes and Type 2 Diabetes.”Shows current ADA guidance on early liver disease detection in people with diabetes or prediabetes.
- MedlinePlus.“Liver Function Tests.”Explains what liver blood tests measure and why results are read together rather than one by one.
Mo Maruf
I created WellFizz to bridge the gap between vague wellness advice and actionable solutions. My mission is simple: to decode the research and give you practical tools you can actually use.
Beyond the data, I am a passionate traveler. I believe that stepping away from the screen to explore new environments is essential for mental clarity and physical vitality.